A public consultation regarding revisions to NICE’s health technology evaluation manual has been initiated. The consultation period, scheduled to last four weeks, will focus on two primary alterations. The first involves the integration of NICE’s proportionate strategy to technology appraisals into the manual. The second concerns a revised methodology for updating technology appraisal recommendations in response to COVID-19 medicines.
The consultation signifies the inaugural update to the NICE health technology evaluations manual since its initial publication in January 2022. The manual delineates the procedures for determining the identification, selection, and routing of topics for NICE guidance, which is developed by the Centre for Health Technology Evaluation (CHTE).
The scope of the manual is comprehensive, covering various aspects of health technology. This includes diagnostics, highly specialized technologies, interventional procedures, medical technologies, and technology appraisal guidance. The consultation aims to refine these elements to keep pace with evolving technology and the changing landscape of health care, particularly in light of the COVID-19 pandemic.
The public consultation presents an opportunity for stakeholders including health practitioners, technology experts, and the general public to provide their input. This collaborative approach aims to ensure the updated manual reflects current best practices and addresses emerging challenges in health technology evaluation.
The consultation process is an integral part of NICE’s commitment to transparency and stakeholder engagement. It underscores the organization’s dedication to maintaining up-to-date guidelines that reflect the latest technological advancements and healthcare trends.
The outcome of the consultation will shape the approach to technology appraisals and the method of updating technology appraisal recommendations for COVID-19 medicines. It will serve as a roadmap for future health technology evaluations, ensuring they are based on the latest evidence and meet the needs of the healthcare community.
The consultation on updates to NICE’s health technology evaluations manual is a crucial step towards refining and enhancing the processes for identifying, selecting, and routing topics for NICE guidance. It is poised to impact the approach to technology appraisals and the updating of technology appraisal recommendations for COVID-19 medicines. It also demonstrates NICE’s commitment to stakeholder engagement and maintaining current, effective guidelines for health technology evaluation.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
